Clarkston Capital Partners’s DexCom DXCM Stock Holding History

Clarkston Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,000	Closed	-$453K	–	170
2022 Q4	$453K	Hold	4,000	–	–	0.01%	123
2022 Q3	$322K	Hold	4,000	–	–	0.01%	143
2022 Q2	$298K	Hold	4,000	–	–	0.01%	149
2022 Q1	$512K	Sell	4,000 -12	-0.3%	-$1.31K	0.01%	134
2021 Q4	$539K	Buy	4,012 +12	+0.3%	+$1.72K	0.01%	116
2021 Q3	$547K	Hold	4,000	–	–	0.01%	103
2021 Q2	$427K	Hold	4,000	–	–	0.01%	111
2021 Q1	$359K	Hold	4,000	–	–	0.01%	120
2020 Q4	$370K	Hold	4,000	–	–	0.01%	95
2020 Q3	$412K	Hold	4,000	–	–	0.01%	85
2020 Q2	$405K	Hold	4,000	–	–	0.01%	80
2020 Q1	$269K	Hold	4,000	–	–	0.01%	85
2019 Q4	$219K	Buy	+4,000	New	+$190K	0.01%	93

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Clarkston Capital Partners's DXCM Position: Q1 2023 in Review

Clarkston Capital Partners sold out of DexCom (DXCM) in Q1 2023, closing a stake of 4,000 shares — an estimated $453K sold.

Clarkston Capital Partners first reported a position in DXCM in Q4 2019 and held it in 13 quarters. The position peaked at $547K in Q3 2021. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

Clarkston Capital Partners reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
Clarkston Capital Partners sold 4,000 DexCom shares in Q1 2023, an estimated $453K.
Clarkston Capital Partners first reported a position in DexCom in Q4 2019 and held it in 13 quarters.
Clarkston Capital Partners's DexCom position peaked at $547K in Q3 2021.
904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Clarkston Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.